Comments
Loading...
MiMedx Group Analyst Ratings and Price Targets | NASDAQ:MDXG | Benzinga
MiMedx Group Inc has a consensus price target of $12.4 based on the ratings of 5 analysts. The high is $14 issued by Mizuho on March 1, 2024. The low is $11 issued by HC Wainwright & Co. on May 1, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Cantor Fitzgerald, and Craig-Hallum on February 27, 2025, August 1, 2024, and August 1, 2024, respectively. With an average price target of $12 between Cantor Fitzgerald, Cantor Fitzgerald, and Craig-Hallum, there's an implied 71.31% upside for MiMedx Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Craig-Hallum
HC Wainwright & Co.
Lake Street
Mizuho
1calculated from analyst ratings
Analyst Ratings for MiMedx Group
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | Buy Now | 85.58% | Cantor Fitzgerald | Ross Osborn45% | $13 → $13 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2024 | Buy Now | 57.03% | Cantor Fitzgerald | Ross Osborn45% | $11 → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2024 | Buy Now | 71.31% | Craig-Hallum | Chase Knickerbocker48% | $14 → $12 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 57.03% | Cantor Fitzgerald | Ross Osborn45% | → $11 | Initiates | → Overweight | Get Alert |
| 05/01/2024 | Buy Now | 57.03% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 71.31% | Lake Street | Brooks O'Neil36% | → $12 | Initiates | → Buy | Get Alert |
| 03/01/2024 | Buy Now | 99.86% | Mizuho | Anthony Petrone65% | $13 → $14 | Maintains | Buy | Get Alert |
| 10/31/2023 | Buy Now | 71.31% | Mizuho | Anthony Petrone65% | $14 → $12 | Maintains | Buy | Get Alert |
| 10/27/2023 | Buy Now | 71.31% | Craig-Hallum | Chase Knickerbocker48% | → $12 | Initiates | → Buy | Get Alert |
| 08/02/2023 | Buy Now | 71.31% | Mizuho | Anthony Petrone65% | $10 → $12 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 57.03% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $8 → $11 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 14.2% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $9.5 → $8 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 35.62% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $8 → $9.5 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | 14.2% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $8 | Reiterates | → Buy | Get Alert |
| 10/13/2022 | Buy Now | -0.07% | Mizuho | Anthony Petrone65% | → $7 | Initiates | → Buy | Get Alert |
| 09/07/2022 | Buy Now | 14.2% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $8.5 → $8 | Maintains | Buy | Get Alert |
FAQ
What is the target price for MiMedx Group (MDXG) stock?
The latest price target for MiMedx Group (NASDAQ:MDXG) was reported by Cantor Fitzgerald on February 27, 2025. The analyst firm set a price target for $13.00 expecting MDXG to rise to within 12 months (a possible 85.58% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MiMedx Group (MDXG)?
The latest analyst rating for MiMedx Group (NASDAQ:MDXG) was provided by Cantor Fitzgerald, and MiMedx Group reiterated their overweight rating.
When was the last upgrade for MiMedx Group (MDXG)?
There is no last upgrade for MiMedx Group
When was the last downgrade for MiMedx Group (MDXG)?
There is no last downgrade for MiMedx Group.
When is the next analyst rating going to be posted or updated for MiMedx Group (MDXG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MiMedx Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MiMedx Group was filed on February 27, 2025 so you should expect the next rating to be made available sometime around February 27, 2026.
Is the Analyst Rating MiMedx Group (MDXG) correct?
While ratings are subjective and will change, the latest MiMedx Group (MDXG) rating was a reiterated with a price target of $13.00 to $13.00. The current price MiMedx Group (MDXG) is trading at is $7.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
